These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16927131)

  • 1. Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide.
    Luo C; Nawa A; Yamauchi Y; Kohno S; Ushijima Y; Goshima F; Kikkawa F; Nishiyama Y
    Virus Genes; 2007 Jun; 34(3):263-72. PubMed ID: 16927131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
    Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
    J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of herpes simplex virus thymidine kinase to VP22 does not result in intercellular trafficking of the protein.
    Beerens AM; Rots MG; de Vries EF; Haisma HJ
    Int J Mol Med; 2007 May; 19(5):841-9. PubMed ID: 17390091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
    Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
    J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.
    Degrève B; Johansson M; De Clercq E; Karlsson A; Balzarini J
    J Virol; 1998 Dec; 72(12):9535-43. PubMed ID: 9811686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
    Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
    J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
    J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The US11 gene product of herpes simplex virus has intercellular trafficking activity.
    Koshizuka T; Takakuwa H; Goshima F; Murata T; Nishiyama Y
    Biochem Biophys Res Commun; 2001 Nov; 288(3):597-602. PubMed ID: 11676485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
    Hayashi K; Hayashi T; Sun HD; Takeda Y
    Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A designed equine herpes thymidine kinase (EHV4 TK) variant improves ganciclovir-induced cell-killing.
    McSorley T; Ort S; Monnerjahn C; Konrad M
    Biochem Pharmacol; 2014 Feb; 87(3):435-44. PubMed ID: 24316433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
    Boucher PD; Ostruszka LJ; Shewach DS
    Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
    Pasanen T; Karppinen A; Alhonen L; Jänne J; Wahlfors J
    Int J Cancer; 2003 Apr; 104(3):380-8. PubMed ID: 12569563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
    Si YJ; Guang LX; Yuan FH; Zhang KB
    Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic expression of herpes simplex virus-thymidine kinase gene in human non-small cell lung cancer cells conferred caspase-activated apoptosis sensitized by ganciclovir.
    Chiu CC; Kang YL; Yang TH; Huang CH; Fang K
    Int J Cancer; 2002 Dec; 102(4):328-33. PubMed ID: 12402300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing effect of the herpes simplex virus thymidine kinase/ganciclovir enzyme/prodrug system on human nasopharyngeal carcinoma cells.
    Tang Y; Li J; Zhao S; Liu J
    J Int Med Res; 2007; 35(4):433-41. PubMed ID: 17697519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
    Rautsi O; Lehmusvaara S; Ketola A; Määttä AM; Wahlfors J; Pellinen R
    Cancer Gene Ther; 2008 May; 15(5):303-14. PubMed ID: 18309353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2000 Dec; 58(6):1326-32. PubMed ID: 11093770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.